Moelis & Company (MC) Competitors $52.34 +0.22 (+0.41%) Closing price 03:59 PM EasternExtended Trading$51.50 -0.84 (-1.60%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MC vs. NMR, CG, GLPI, DOC, AMH, WPC, REG, LINE, FUTU, and HLIShould you be buying Moelis & Company stock or one of its competitors? The main competitors of Moelis & Company include Nomura (NMR), The Carlyle Group (CG), Gaming and Leisure Properties (GLPI), Healthpeak Properties (DOC), American Homes 4 Rent (AMH), W. P. Carey (WPC), Regency Centers (REG), Lineage (LINE), Futu (FUTU), and Houlihan Lokey (HLI). These companies are all part of the "trading" industry. Moelis & Company vs. Nomura The Carlyle Group Gaming and Leisure Properties Healthpeak Properties American Homes 4 Rent W. P. Carey Regency Centers Lineage Futu Houlihan Lokey Moelis & Company (NYSE:MC) and Nomura (NYSE:NMR) are both finance companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, valuation, earnings, profitability, community ranking, media sentiment and analyst recommendations. Which has higher earnings & valuation, MC or NMR? Nomura has higher revenue and earnings than Moelis & Company. Nomura is trading at a lower price-to-earnings ratio than Moelis & Company, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMoelis & Company$1.19B3.28$136.02M$1.7629.74Nomura$1.67T0.01$1.14B$0.707.76 Does the MarketBeat Community favor MC or NMR? Moelis & Company received 75 more outperform votes than Nomura when rated by MarketBeat users. Likewise, 55.22% of users gave Moelis & Company an outperform vote while only 53.86% of users gave Nomura an outperform vote. CompanyUnderperformOutperformMoelis & CompanyOutperform Votes31255.22% Underperform Votes25344.78% NomuraOutperform Votes23753.86% Underperform Votes20346.14% Does the media favor MC or NMR? In the previous week, Moelis & Company had 25 more articles in the media than Nomura. MarketBeat recorded 26 mentions for Moelis & Company and 1 mentions for Nomura. Moelis & Company's average media sentiment score of 0.51 beat Nomura's score of 0.00 indicating that Moelis & Company is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Moelis & Company 9 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Nomura 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is MC or NMR more profitable? Moelis & Company has a net margin of 11.39% compared to Nomura's net margin of 7.96%. Moelis & Company's return on equity of 38.49% beat Nomura's return on equity.Company Net Margins Return on Equity Return on Assets Moelis & Company11.39% 38.49% 14.03% Nomura 7.96%9.19%0.56% Do institutionals and insiders have more ownership in MC or NMR? 91.5% of Moelis & Company shares are owned by institutional investors. Comparatively, 15.1% of Nomura shares are owned by institutional investors. 6.4% of Moelis & Company shares are owned by insiders. Comparatively, 0.0% of Nomura shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is MC or NMR a better dividend stock? Moelis & Company pays an annual dividend of $2.60 per share and has a dividend yield of 5.0%. Nomura pays an annual dividend of $0.26 per share and has a dividend yield of 4.8%. Moelis & Company pays out 147.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Nomura pays out 37.1% of its earnings in the form of a dividend. Which has more risk and volatility, MC or NMR? Moelis & Company has a beta of 1.53, suggesting that its stock price is 53% more volatile than the S&P 500. Comparatively, Nomura has a beta of 0.65, suggesting that its stock price is 35% less volatile than the S&P 500. Do analysts recommend MC or NMR? Moelis & Company presently has a consensus price target of $62.50, indicating a potential upside of 19.42%. Given Moelis & Company's higher probable upside, equities analysts plainly believe Moelis & Company is more favorable than Nomura.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Moelis & Company 2 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.86Nomura 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryMoelis & Company beats Nomura on 16 of the 20 factors compared between the two stocks. Remove Ads Get Moelis & Company News Delivered to You Automatically Sign up to receive the latest news and ratings for MC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MC vs. The Competition Export to ExcelMetricMoelis & CompanyInvestment advice IndustryFinance SectorNYSE ExchangeMarket Cap$3.92B$10.11B$10.85B$18.51BDividend Yield4.79%24.84%6.00%4.24%P/E Ratio29.7434.8221.5931.15Price / Sales3.287.2725.4325.69Price / Cash34.2617.7117.6117.53Price / Book10.283.412.574.29Net Income$136.02M$411.75M$1.03B$1.02B7 Day Performance7.28%9.10%3.88%6.59%1 Month Performance-12.20%-6.23%-3.47%-6.88%1 Year Performance1.17%0.28%535.31%1.23% Moelis & Company Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MCMoelis & Company2.911 of 5 stars$52.34+0.4%$62.50+19.4%+0.3%$3.92B$1.19B29.741,161NMRNomura3.3755 of 5 stars$5.03-2.8%N/A-11.6%$14.93B$1.67T7.1826,600High Trading VolumeCGThe Carlyle Group4.87 of 5 stars$36.92+2.9%$53.25+44.2%-20.1%$13.34B$3.40B13.282,100Analyst ForecastHigh Trading VolumeGLPIGaming and Leisure Properties4.3382 of 5 stars$46.49-2.9%$54.11+16.4%+12.7%$12.78B$1.53B16.2020News CoveragePositive NewsDOCHealthpeak Properties4.6423 of 5 stars$18.20-1.3%$23.83+31.0%+0.8%$12.73B$543.46M51.99200Dividend AnnouncementAnalyst DowngradeAnalyst RevisionNews CoveragePositive NewsHigh Trading VolumeAMHAmerican Homes 4 Rent4.2739 of 5 stars$34.01-4.1%$40.23+18.3%+0.8%$12.59B$1.73B31.491,790WPCW. P. Carey3.3017 of 5 stars$56.94-3.7%$63.75+12.0%+8.8%$12.47B$1.58B27.25190Short Interest ↑News CoveragePositive NewsREGRegency Centers3.7079 of 5 stars$67.54-1.8%$78.00+15.5%+20.4%$12.26B$1.45B31.86440Positive NewsLINELineage3.9449 of 5 stars$51.25-5.7%$79.67+55.4%N/A$11.70B$5.34B0.0026,127FUTUFutu4.4396 of 5 stars$79.11-5.3%$121.20+53.2%+48.3%$10.90B$13.59B19.392,320News CoveragePositive NewsGap DownHigh Trading VolumeHLIHoulihan Lokey4.5341 of 5 stars$143.74-1.8%$185.20+28.8%+24.4%$10.08B$2.24B27.432,260High Trading Volume Remove Ads Related Companies and Tools Related Companies NMR Competitors CG Competitors GLPI Competitors DOC Competitors AMH Competitors WPC Competitors REG Competitors LINE Competitors FUTU Competitors HLI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:MC) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moelis & Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Moelis & Company With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
